Previous 10 | Next 10 |
HOUSTON , May 14, 2019 /PRNewswire/ -- Moleculin Biotech, Inc. (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its financial results for the firs...
Bridgeline Digital (NASDAQ: BLIN ) +37% on announcing OrchestraCMS multi-year license renewal with global biopharmaceutical company. More news on: Bridgeline Digital, Inc., Akorn, Inc., Akoustis Technologies, Inc., Stocks on the move, Read more ...
Biotech Stocks: Why Expensive U.S. Drug Trials Are Pushing Pharma Research Overseas May 7, 2019 Palm Beach, FL –May 7, 2019 – American pharmaceutical and biotech companies who need to conduct clinical trials are looking more and more to conduct them overseas in the Europe...
HOUSTON , May 7, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced additional positive interim safety and ef...
Precipio (NASDAQ: PRPO ) +38% on first major international services contract. More news on: Precipio, Inc., Innovate Biopharmaceuticals, Inc., Changyou.com Limited, Stocks on the move, Read more ...
MIRAMAR, Florida , April 29, 2019 /PRNewswire/ -- Launch of ExcellagenÒ for Wound Healing by subsidiary Olaregen Therapeutix Pending completion of acquisitions: Pantheon Medical, MediSource Partners, and Fuse Medical, Financing initiatives S1 Filing Applicati...
VANCOUVER, British Columbia , April 29, 2019 /PRNewswire/ -- Highlights US$217 million ( Cdn$290 million ) after-tax Net Present Value at 8% discount rate and Internal Rate of Return of 28.0%; PEA based on a production rate of 5,000 tonnes of lithium carbonate...
HOUSTON , April 29, 2019 /PRNewswire/ -- A small public company with 6 highly promising anti-cancer drugs in the pipeline is augmenting US clinical trials with trials in Poland , speeding the process of patient recruitment and data collection. The company, Moleculin (NASDAQ: MBRX), ...
Moxian (NASDAQ: MOXC ) -10% . More news on: Moxian, Inc., SandRidge Permian Trust, Bitauto Holdings Limited, Stocks on the move, , Read more ...
Gainers: Tiziana Life Sciences (NASDAQ: TLSA ) +35% . Appliance Recycling Centers of America (NASDAQ: ARCI ) +24% . Travelzoo (NASDAQ: TZOO ) +18% . Socket Mobile (NASDAQ: SCKT ) +16% . AXT (NASDAQ: AXTI ) +15% . Atossa Genetics (NASDAQ: ATOS ) +12% . Brightcove (NASDAQ: BCOV )...
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial PR Newswire Based on an encouraging discussion in the End of Phase 1B /2 Meeting with FDA the Company plans to: Proceed with a pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) designed for po...
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...